Longitudinal health-related quality of life assessment implications for prognosis in stage IV pancreatic cancer
We investigated whether changes in quality of life (QoL) during treatment could predict survival in stage IV pancreatic cancer. Quality of life was evaluated at baseline and after 3 months of treatment using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EO...
Gespeichert in:
| Veröffentlicht in: | Pancreas 2013-03, Vol.42 (2), p.254-259 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 259 |
|---|---|
| container_issue | 2 |
| container_start_page | 254 |
| container_title | Pancreas |
| container_volume | 42 |
| creator | Braun, Donald P Gupta, Digant Staren, Edgar D |
| description | We investigated whether changes in quality of life (QoL) during treatment could predict survival in stage IV pancreatic cancer.
Quality of life was evaluated at baseline and after 3 months of treatment using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) in 186 patients with stage IV pancreatic cancer. Cox regression evaluated the prognostic significance of baseline and changes in QoL scores after adjusting for age, sex, and treatment history.
One hundred twenty-one patients were males and 65 were females. One hundred twenty-seven patients' condition was newly diagnosed, whereas 59 were previously treated. The mean age at diagnosis was 55.1 years. Baseline QoL scale predictive of survival upon multivariate analysis was global health (hazard ratio, 0.88; 95% confidence interval, 0.81-0.95; P = 0.001). On multivariate analysis, QoL change variable that was significantly predictive of survival after 3 months of treatment was cognitive function (hazard ratio, 0.89; 95% confidence interval, 0.79-0.99; P = 0.04).
This study provides preliminary evidence to indicate that patients with stage IV pancreatic cancer who have a better global health at baseline as well as those whose cognitive function improves within 3 months of treatment have a significantly increased probability of survival. |
| doi_str_mv | 10.1097/mpa.0b013e31825b9f56 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1324391690</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1324391690</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-3e8691982aea3c79f9aca5302f3b41f711e2945a9de3484863111f780932962f3</originalsourceid><addsrcrecordid>eNpdkD1vGzEMhoWiQeO4_QdFobHLpZJ4H9JoGE0TwEUzJFkPtEw5KnSni6Qb_O9zRT6GTiSI5yWJh7GvUlxKYbofw4SXYi8kEEitmr1xTfuBrWQDbVVrpT-yldC6qUB23Tm7yPmvELKDxnxi50rpRrSqXbG4i-PRl_ngRwz8kTCUxypRwEIH_jRj8OXEo-PBO-KYM-U80Fi4H6bgLRYfx8xdTHxK8TjG7DP3I88Fj8RvHviEo020YJbbpaX0mZ05DJm-vNY1u7_6ebe9rnZ_ft1sN7vKQgelAtKtkUYrJATbGWfQYgNCOdjX0nVSkjJ1g-ZAUOtatyDlMtbCgDLtQq3Z95e9y19PM-XSDz5bCgFHinPuJagajGyNWND6BbUp5pzI9VPyA6ZTL0X_T3X_-3bT_696iX17vTDvBzq8h97cwjONoHxi</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1324391690</pqid></control><display><type>article</type><title>Longitudinal health-related quality of life assessment implications for prognosis in stage IV pancreatic cancer</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Braun, Donald P ; Gupta, Digant ; Staren, Edgar D</creator><creatorcontrib>Braun, Donald P ; Gupta, Digant ; Staren, Edgar D</creatorcontrib><description>We investigated whether changes in quality of life (QoL) during treatment could predict survival in stage IV pancreatic cancer.
Quality of life was evaluated at baseline and after 3 months of treatment using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) in 186 patients with stage IV pancreatic cancer. Cox regression evaluated the prognostic significance of baseline and changes in QoL scores after adjusting for age, sex, and treatment history.
One hundred twenty-one patients were males and 65 were females. One hundred twenty-seven patients' condition was newly diagnosed, whereas 59 were previously treated. The mean age at diagnosis was 55.1 years. Baseline QoL scale predictive of survival upon multivariate analysis was global health (hazard ratio, 0.88; 95% confidence interval, 0.81-0.95; P = 0.001). On multivariate analysis, QoL change variable that was significantly predictive of survival after 3 months of treatment was cognitive function (hazard ratio, 0.89; 95% confidence interval, 0.79-0.99; P = 0.04).
This study provides preliminary evidence to indicate that patients with stage IV pancreatic cancer who have a better global health at baseline as well as those whose cognitive function improves within 3 months of treatment have a significantly increased probability of survival.</description><identifier>ISSN: 0885-3177</identifier><identifier>EISSN: 1536-4828</identifier><identifier>DOI: 10.1097/mpa.0b013e31825b9f56</identifier><identifier>PMID: 22850626</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Cognition ; Emotions ; Female ; Health Status ; Humans ; Kaplan-Meier Estimate ; Longitudinal Studies ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasm Staging ; Pancreatic Neoplasms - mortality ; Pancreatic Neoplasms - pathology ; Pancreatic Neoplasms - psychology ; Pancreatic Neoplasms - therapy ; Proportional Hazards Models ; Quality of Life ; Registries ; Retrospective Studies ; Social Behavior ; Surveys and Questionnaires ; Time Factors ; Treatment Outcome ; United States ; Young Adult</subject><ispartof>Pancreas, 2013-03, Vol.42 (2), p.254-259</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-3e8691982aea3c79f9aca5302f3b41f711e2945a9de3484863111f780932962f3</citedby><cites>FETCH-LOGICAL-c373t-3e8691982aea3c79f9aca5302f3b41f711e2945a9de3484863111f780932962f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22850626$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Braun, Donald P</creatorcontrib><creatorcontrib>Gupta, Digant</creatorcontrib><creatorcontrib>Staren, Edgar D</creatorcontrib><title>Longitudinal health-related quality of life assessment implications for prognosis in stage IV pancreatic cancer</title><title>Pancreas</title><addtitle>Pancreas</addtitle><description>We investigated whether changes in quality of life (QoL) during treatment could predict survival in stage IV pancreatic cancer.
Quality of life was evaluated at baseline and after 3 months of treatment using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) in 186 patients with stage IV pancreatic cancer. Cox regression evaluated the prognostic significance of baseline and changes in QoL scores after adjusting for age, sex, and treatment history.
One hundred twenty-one patients were males and 65 were females. One hundred twenty-seven patients' condition was newly diagnosed, whereas 59 were previously treated. The mean age at diagnosis was 55.1 years. Baseline QoL scale predictive of survival upon multivariate analysis was global health (hazard ratio, 0.88; 95% confidence interval, 0.81-0.95; P = 0.001). On multivariate analysis, QoL change variable that was significantly predictive of survival after 3 months of treatment was cognitive function (hazard ratio, 0.89; 95% confidence interval, 0.79-0.99; P = 0.04).
This study provides preliminary evidence to indicate that patients with stage IV pancreatic cancer who have a better global health at baseline as well as those whose cognitive function improves within 3 months of treatment have a significantly increased probability of survival.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Cognition</subject><subject>Emotions</subject><subject>Female</subject><subject>Health Status</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Neoplasm Staging</subject><subject>Pancreatic Neoplasms - mortality</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Pancreatic Neoplasms - psychology</subject><subject>Pancreatic Neoplasms - therapy</subject><subject>Proportional Hazards Models</subject><subject>Quality of Life</subject><subject>Registries</subject><subject>Retrospective Studies</subject><subject>Social Behavior</subject><subject>Surveys and Questionnaires</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>United States</subject><subject>Young Adult</subject><issn>0885-3177</issn><issn>1536-4828</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkD1vGzEMhoWiQeO4_QdFobHLpZJ4H9JoGE0TwEUzJFkPtEw5KnSni6Qb_O9zRT6GTiSI5yWJh7GvUlxKYbofw4SXYi8kEEitmr1xTfuBrWQDbVVrpT-yldC6qUB23Tm7yPmvELKDxnxi50rpRrSqXbG4i-PRl_ngRwz8kTCUxypRwEIH_jRj8OXEo-PBO-KYM-U80Fi4H6bgLRYfx8xdTHxK8TjG7DP3I88Fj8RvHviEo020YJbbpaX0mZ05DJm-vNY1u7_6ebe9rnZ_ft1sN7vKQgelAtKtkUYrJATbGWfQYgNCOdjX0nVSkjJ1g-ZAUOtatyDlMtbCgDLtQq3Z95e9y19PM-XSDz5bCgFHinPuJagajGyNWND6BbUp5pzI9VPyA6ZTL0X_T3X_-3bT_696iX17vTDvBzq8h97cwjONoHxi</recordid><startdate>201303</startdate><enddate>201303</enddate><creator>Braun, Donald P</creator><creator>Gupta, Digant</creator><creator>Staren, Edgar D</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201303</creationdate><title>Longitudinal health-related quality of life assessment implications for prognosis in stage IV pancreatic cancer</title><author>Braun, Donald P ; Gupta, Digant ; Staren, Edgar D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-3e8691982aea3c79f9aca5302f3b41f711e2945a9de3484863111f780932962f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Cognition</topic><topic>Emotions</topic><topic>Female</topic><topic>Health Status</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Neoplasm Staging</topic><topic>Pancreatic Neoplasms - mortality</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Pancreatic Neoplasms - psychology</topic><topic>Pancreatic Neoplasms - therapy</topic><topic>Proportional Hazards Models</topic><topic>Quality of Life</topic><topic>Registries</topic><topic>Retrospective Studies</topic><topic>Social Behavior</topic><topic>Surveys and Questionnaires</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>United States</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Braun, Donald P</creatorcontrib><creatorcontrib>Gupta, Digant</creatorcontrib><creatorcontrib>Staren, Edgar D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pancreas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Braun, Donald P</au><au>Gupta, Digant</au><au>Staren, Edgar D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Longitudinal health-related quality of life assessment implications for prognosis in stage IV pancreatic cancer</atitle><jtitle>Pancreas</jtitle><addtitle>Pancreas</addtitle><date>2013-03</date><risdate>2013</risdate><volume>42</volume><issue>2</issue><spage>254</spage><epage>259</epage><pages>254-259</pages><issn>0885-3177</issn><eissn>1536-4828</eissn><abstract>We investigated whether changes in quality of life (QoL) during treatment could predict survival in stage IV pancreatic cancer.
Quality of life was evaluated at baseline and after 3 months of treatment using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) in 186 patients with stage IV pancreatic cancer. Cox regression evaluated the prognostic significance of baseline and changes in QoL scores after adjusting for age, sex, and treatment history.
One hundred twenty-one patients were males and 65 were females. One hundred twenty-seven patients' condition was newly diagnosed, whereas 59 were previously treated. The mean age at diagnosis was 55.1 years. Baseline QoL scale predictive of survival upon multivariate analysis was global health (hazard ratio, 0.88; 95% confidence interval, 0.81-0.95; P = 0.001). On multivariate analysis, QoL change variable that was significantly predictive of survival after 3 months of treatment was cognitive function (hazard ratio, 0.89; 95% confidence interval, 0.79-0.99; P = 0.04).
This study provides preliminary evidence to indicate that patients with stage IV pancreatic cancer who have a better global health at baseline as well as those whose cognitive function improves within 3 months of treatment have a significantly increased probability of survival.</abstract><cop>United States</cop><pmid>22850626</pmid><doi>10.1097/mpa.0b013e31825b9f56</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0885-3177 |
| ispartof | Pancreas, 2013-03, Vol.42 (2), p.254-259 |
| issn | 0885-3177 1536-4828 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1324391690 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Adult Aged Aged, 80 and over Cognition Emotions Female Health Status Humans Kaplan-Meier Estimate Longitudinal Studies Male Middle Aged Multivariate Analysis Neoplasm Staging Pancreatic Neoplasms - mortality Pancreatic Neoplasms - pathology Pancreatic Neoplasms - psychology Pancreatic Neoplasms - therapy Proportional Hazards Models Quality of Life Registries Retrospective Studies Social Behavior Surveys and Questionnaires Time Factors Treatment Outcome United States Young Adult |
| title | Longitudinal health-related quality of life assessment implications for prognosis in stage IV pancreatic cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T11%3A42%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Longitudinal%20health-related%20quality%20of%20life%20assessment%20implications%20for%20prognosis%20in%20stage%20IV%20pancreatic%20cancer&rft.jtitle=Pancreas&rft.au=Braun,%20Donald%20P&rft.date=2013-03&rft.volume=42&rft.issue=2&rft.spage=254&rft.epage=259&rft.pages=254-259&rft.issn=0885-3177&rft.eissn=1536-4828&rft_id=info:doi/10.1097/mpa.0b013e31825b9f56&rft_dat=%3Cproquest_cross%3E1324391690%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1324391690&rft_id=info:pmid/22850626&rfr_iscdi=true |